Survival | Non-survival | p | |
---|---|---|---|
24-h survival | |||
RCC (units) | 7.3 +/- 5.3 | 17.7 +/- 7.8 | 0.035 |
FFP (units) | 3.6 +/- 4.2 | 12.0 +/- 6.9 | 0.02 |
PC (units) | 5.7 +/- 12.9 | 13.3 +/- 11.5 | 0.271 |
RCC/FFP ratio | 1.3 +/- 0.6 | 1.6 +/- 0.8 | 0.014 |
RCC/FFP >1.5 L (n) | 2 (9 %) | 3 (100 %) | 0.018 |
RCC - FFP (units) | 4.5 +/- 4.7 | 5.7 +/- 5.7 | 0.006 |
Preoperative crystalloid volume (mL) | 877 +/- 615 | 2333 +/- 1041 | 0.01 |
Total crystalloid volume (mL) | 2386 +/- 912 | 5083 +/-803 | 0.028 |
Total crystalloid >1.5 L (n) | 5 (23 %) | 3 (100 %) | 0.037 |
30-day survival | |||
RCC (units) | 6.9 +/- 5.6 | 15.8 +/- 7.4 | 0.017 |
FFP (units) | 3.4 +/- 4.2 | 10.0 +/- 6.9 | 0.116 |
PC (units) | 5.7 +/- 12.9 | 10.0 +/- 11.5 | 0.96 |
RCC/FFP ratio | 1.1 +/- 0.6 | 1.8 +/- 0.8 | 0.001 |
RCC/FFP > 1.5 L (n) | 1 (5 %) | 4 (70 %) | 0.03 |
RCC - FFP (units) | 3.5+/-4.7 | 5.8+/-4.6 | 0.03 |
Preoperative crystalloid volume (mL) | 847 +/- 615 | 2125 +/- 946 | 0.003 |
Total crystalloid volume (mL) | 2341 +/- 9.6 | 4550 +/- 1252 | 0.012 |
Crystalloids >1.5 L (n) | 5 (25 %) | 4 (80 %) | 0.01 |